Description

Yantai Dongcheng Pharmaceutical Group Co.,Ltd., along with its subsidiaries, operates primarily in China, focusing on the development, manufacturing, and sale of a diverse portfolio of pharmaceutical products. These offerings span biochemical active pharmaceutical ingredients (APIs), conventional chemical medicines, traditional Chinese medicines, and advanced nuclide drugs. The company's product range features compounds such as heparin, chondroitin sulphate, and glucosamine series, alongside collagen, hyaluronic acid, and cytochrome C. These are applied across various therapeutic areas, including cardiovascular health, oncology, urology, and orthopedics. Beyond its domestic operations, Yantai Dongcheng Pharmaceutical Group also maintains an international presence, exporting its goods to approximately 40 countries and regions globally, encompassing markets in Europe, the Americas, and the Asia Pacific. The company was founded in 1998 and is headquartered in Yantai, China.